Complera

Indicated For

HIV infection, HIV treatment

About This Medication

# Gilead Advancing Access Guide: Getting Complera at Low Cost ## About This Program Complera (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) is a combination medication used to treat HIV infection. If you're struggling to afford Complera, the Gilead Advancing Access Patient Assistance Program (PAP) and Medication Assistance Program (MAP) can help. This program provides free or reduced-cost medication to eligible patients. ## Who Can Apply? Gilead's assistance programs are available to patients with most insurance types: - **Uninsured patients** – Apply through PAP/MAP for free medication - **Underinsured patients** – Apply through PAP/MAP if copays are too high - **Commercially insured patients** – Access a co-pay savings program to reduce out-of-pocket costs - **Medicare/Medicaid patients** – Both co-pay assistance and PAP/MAP options available You do not need to be uninsured to qualify. Many insured patients save thousands annually through this program. ## Income Requirements Income limits vary based on your household size and location. The program uses federal poverty guidelines with flexibility built in. Most patients earning up to 400-500% of the federal poverty level qualify, though exact limits vary. During your application, the program will explain the specific income threshold for your situation. **Federal Poverty Guidelines (2024 reference):** - Individual: ~$14,580 - Family of 2: ~$19,720 - Family of 3: ~$24,860 - Family of 4: ~$30,000 Income limits for the assistance program are significantly higher than these figures. Call to confirm your household's eligibility. ## What Documents You'll Need Have these items ready before you call: 1. **Proof of income** – Recent pay stubs, tax return (last 2 years), Social Security statement, or unemployment benefits letter 2. **Current prescription** – Your doctor's prescription for Complera 3. **Insurance information** – Insurance card (if applicable) or confirmation you are uninsured 4. **Contact information** – Phone number and mailing address Make copies of income documents before submitting. Keep originals for your records. ## How to Apply: 4 Easy Steps **Step 1: Call the Program** Contact Gilead Advancing Access at **(800) 226-2056**. Representatives are available to guide you through the entire process. **Step 2: Speak with a Counselor** A program counselor will ask about your income, insurance status, and medication needs. They'll verify your eligibility and explain your options. **Step 3: Submit Documents** Mail or fax your income proof and prescription. The program will provide a fax number and mailing address during your call. **Step 4: Receive Your Medication** Once approved, medication is shipped directly to you or your pharmacy, usually within 5-10 business days. ## Timeline and What to Expect - **Phone call:** 15-30 minutes - **Document review:** 3-5 business days - **Approval decision:** Usually within 1 week - **Medication delivery:** 5-10 business days after approval - **Total process:** Typically 2-3 weeks from initial call to receiving medication ## Annual Reauthorization Your assistance is renewed annually. The program will contact you when it's time to reauthorize. Be prepared to provide updated income documentation each year. ## Savings Card Option If you have commercial insurance, you may qualify for Gilead's co-pay savings card. This card dramatically reduces your out-of-pocket costs each month—some patients pay as little as $0-$50 per prescription. Ask about this option when you call. ## Next Steps 1. Gather your income proof and prescription 2. Call **(800) 226-2056** to start your application 3. Follow the counselor's instructions for submitting documents 4. Keep your contact information updated 5. Plan for annual reauthorization ## Additional Resources Visit **https://www.gileadadvancingaccess.com/patient** for more information, FAQs, and to download application forms. You can also mail applications if calling isn't convenient. The program is free to use, confidential, and designed to help you access the HIV treatment you need without financial hardship.

Program information last verified: March 25, 2026